Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Farglitazar (GI-262570) is a PPAR-γ agonist and insulin sensitizer that inhibits stellate cell activation by activating receptor γ via oxidative enzymes proliferators and is used in the study of diabetes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 293.00 | |
5 mg | In stock | $ 722.00 | |
10 mg | In stock | $ 987.00 | |
25 mg | In stock | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 |
Description | Farglitazar (GI-262570) is a PPAR-γ agonist and insulin sensitizer that inhibits stellate cell activation by activating receptor γ via oxidative enzymes proliferators and is used in the study of diabetes. |
Synonyms | GI-262570, GI-2570, GW 262570X, GI 262570, GI262570 |
Molecular Weight | 546.612 |
Formula | C34H30N2O5 |
CAS No. | 196808-45-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Farglitazar 196808-45-4 DNA Damage/DNA Repair Metabolism PPAR GI-262570 GI-2570 GW 262570X GI 262570 GI262570 inhibitor inhibit